Parallel Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
Parallel Advisors's TNDM Position: Q3 2026 in Review
Parallel Advisors held its Tandem Diabetes Care (TNDM) position steady in Q3 2026 at 65 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.
Parallel Advisors first reported a position in TNDM in Q4 2021 and has held it in 20 quarters since. The position peaked at $52.7K in Q2 2024. 77 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.
- Parallel Advisors held 65 shares of Tandem Diabetes Care worth $1.06K as of Q3 2026.
- Parallel Advisors left its Tandem Diabetes Care share count unchanged in Q3 2026.
- Tandem Diabetes Care made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3772 holding.
- Parallel Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 20 quarters since.
- Parallel Advisors's Tandem Diabetes Care position peaked at $52.7K in Q2 2024.
- 77 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.